Company Filing History:
Years Active: 2016-2018
Title: Meixia Yu: Innovator in Biocompatible Macromolecule Derivatives
Introduction
Meixia Yu is a prominent inventor based in Jiangsu, China. He has made significant contributions to the field of biocompatible macromolecules, focusing on innovative derivatives that enhance their functionality and application in medicine.
Latest Patents
Meixia Yu holds 2 patents, with his latest invention being a mercapto-modified biocompatible macromolecule derivative with a low degree of mercapto-modification. This invention not only preserves the initial structure, physiological function, and biocompatibility of the macromolecule but also enables the creation of cross-linked materials with a low degree of cross-linking. The disulfide-bond cross-linked biocompatible macromolecule material developed by Yu effectively prolongs turnover and reduces solubility in vivo, making it suitable for various clinical applications.
Career Highlights
Meixia Yu is associated with Bioregen Biomedical (Changzhou) Co., Ltd., where he continues to advance research in biocompatible materials. His work is pivotal in developing materials that meet the stringent requirements of the medical and pharmaceutical fields.
Collaborations
Meixia Yu collaborates with notable colleagues, including Xiaozheng Shu and Weiping Zhong, who contribute to his research endeavors and innovations.
Conclusion
Meixia Yu's work in biocompatible macromolecule derivatives showcases his commitment to advancing medical technology. His innovative patents reflect a deep understanding of material science and its applications in healthcare.